These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 16239593

  • 1. Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein.
    Rodríguez-Lee M, Ostergren-Lundén G, Wallin B, Moses J, Bondjers G, Camejo G.
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):130-5. PubMed ID: 16239593
    [Abstract] [Full Text] [Related]

  • 2. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
    Fager G, Camejo G, Olsson U, Ostergren-Lundén G, Lustig F, Bondjers G.
    J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents.
    de Dios ST, Frontanilla KV, Nigro J, Ballinger ML, Ivey ME, Cawson EA, Little PJ.
    J Diabetes Complications; 2007 May; 21(2):108-17. PubMed ID: 17331859
    [Abstract] [Full Text] [Related]

  • 4. Fatty acid-induced atherogenic changes in extracellular matrix proteoglycans.
    Rodriguéz-Lee M, Bondjers G, Camejo G.
    Curr Opin Lipidol; 2007 Oct; 18(5):546-53. PubMed ID: 17885426
    [Abstract] [Full Text] [Related]

  • 5. Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins.
    Olsson U, Bondjers G, Camejo G.
    Diabetes; 1999 Mar; 48(3):616-22. PubMed ID: 10078565
    [Abstract] [Full Text] [Related]

  • 6. Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding.
    Ballinger ML, Osman N, Wilks AF, Su S, Burns CJ, Bu X, Little PJ.
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):403-12. PubMed ID: 19033819
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells.
    Lemire JM, Chan CK, Bressler S, Miller J, LeBaron RG, Wight TN.
    J Cell Biochem; 2007 Jun 01; 101(3):753-66. PubMed ID: 17226775
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells.
    Camejo G, Fager G, Rosengren B, Hurt-Camejo E, Bondjers G.
    J Biol Chem; 1993 Jul 05; 268(19):14131-7. PubMed ID: 8314779
    [Abstract] [Full Text] [Related]

  • 11. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
    Wang ZJ, Ding WH, Shi LB, Bu DF, Ren ZW, Tang CS.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 24; 86(4):242-6. PubMed ID: 16677503
    [Abstract] [Full Text] [Related]

  • 12. Role of proteoglycan in the binding of low-density lipoprotein to cultured arterial smooth muscle cells.
    Horn-Brahimi MC, Breton M, Berrou E, Deudon E, Picard J.
    Artery; 1988 Jan 24; 15(3):122-39. PubMed ID: 3365121
    [Abstract] [Full Text] [Related]

  • 13. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.
    Ivey ME, Little PJ.
    Thromb Res; 2008 Jan 24; 123(2):288-97. PubMed ID: 18571697
    [Abstract] [Full Text] [Related]

  • 14. PPAR agonists in the treatment of insulin resistance and associated arterial disease.
    Camejo G.
    Int J Clin Pract Suppl; 2003 Mar 24; (134):36-44. PubMed ID: 12793596
    [Abstract] [Full Text] [Related]

  • 15. High glucose-induced alterations in subendothelial matrix perlecan leads to increased monocyte binding.
    Vogl-Willis CA, Edwards IJ.
    Arterioscler Thromb Vasc Biol; 2004 May 24; 24(5):858-63. PubMed ID: 15031130
    [Abstract] [Full Text] [Related]

  • 16. PDGF-stimulated cell proliferation and migration of human arterial smooth muscle cells. Colocalization of PDGF isoforms with glycosaminoglycans.
    García-Olivas R, Vilaró S, Reina M, Castel S.
    Int J Biochem Cell Biol; 2007 May 24; 39(10):1915-29. PubMed ID: 17616478
    [Abstract] [Full Text] [Related]

  • 17. Proteoglycans in pathological conditions: atherosclerosis.
    Wight TN.
    Fed Proc; 1985 Feb 24; 44(2):381-5. PubMed ID: 3881292
    [Abstract] [Full Text] [Related]

  • 18. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells.
    Limor R, Sharon O, Knoll E, Many A, Weisinger G, Stern N.
    Am J Hypertens; 2008 Feb 24; 21(2):219-23. PubMed ID: 18202670
    [Abstract] [Full Text] [Related]

  • 19. Compositional and structural alterations of proteoglycans in human rectum carcinoma with special reference to versican and decorin.
    Tsara ME, Theocharis AD, Theocharis DA.
    Anticancer Res; 2002 Feb 24; 22(5):2893-8. PubMed ID: 12530013
    [Abstract] [Full Text] [Related]

  • 20. Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity.
    Schwarz M, Spath L, Lux CA, Paprotka K, Torzewski M, Dersch K, Koch-Brandt C, Husmann M, Bhakdi S.
    Thromb Haemost; 2008 Jul 24; 100(1):110-8. PubMed ID: 18612545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.